Immunoglobulin Superfamily, Member 8 (IGSF8) (Middle Region) Peptide
Quick Overview for Immunoglobulin Superfamily, Member 8 (IGSF8) (Middle Region) Peptide (ABIN8102973)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- IGSF8 Peptide - middle region
-
Sequence
- LAVEAGAPYA ERLAAGELRL GKEGTDRYRM VVGGAQAGDA GTYHCTAAEW
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-IGSF8 Antibody (ARP59875_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- IGSF8 (Immunoglobulin Superfamily, Member 8 (IGSF8))
-
Background
-
Background Information: IGSF8 may play a key role in diverse functions ascribed to CD81 and CD9 such as oocytes fertilization or hepatitis C virus function. IGSF8 may regulate proliferation and differentiation of keratinocytes. IGSF8 may be a negative regulator of cell motility: suppresses T-cell mobility coordinately with CD81, associates with CD82 to suppress prostate cancer cell migration, regulates epidermoid cell reaggregation and motility on laminin-5 with CD9 and CD81 as key linkers. IGSF8 may also play a role on integrin-dependent morphology and motility functions. IGSF8 may participate in the regulation of neurite outgrowth and maintenance of the neural network in the adult brain.
Alternative Symbols: CD316, CD81P3, EWI2, PGRL, EWI-2, KCT-4, LIR-D1
-
Molecular Weight
- 65kDa
-
Gene ID
- 93185
-
NCBI Accession
- NP_443100
-
UniProt
- Q969P0
Target
-
